BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human ...

Russian President Vladimir Putin first hinted at the possibility of a cancer vaccine in February 2024, claiming that Russian ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

The Biden administration releases a 'road map' for maintaining defenses against infectious diseases, as President-elect Trump ...

Moderna provided updates on key elements of its pipeline, including a next-generation COVID-19 vaccine, an RSV vaccine, a new ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...

Vaccine maker Moderna's (NASDAQ: MRNA) stock prices fell by over 16% on 13th January to close at £28.81 ($35.15) after the ...